| Home : ImaginAb's Prostate Imaging Phase I/IIa data will be presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, alongside pre-clinical CD3+ T-cell imaging data |
|
Jun 06
2015 |
ImaginAb's Prostate Imaging Phase I/IIa data will be presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, alongside pre-clinical CD3+ T-cell imaging data |
|
LOS ANGELES, June 5, 2015 /PRNewswire/ -- Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting ImaginAb's Phase I/IIa clinical imaging data with IAB2M in patients with metastatic prostate cancer. IAB2M is an anti-PSMA recombinant antibody fragment (a "minibody") derived... |
|
|
|
| Source:http://www.prnewswire.com/news-releases/imaginabs-prostate-imaging-phase-iiia-data-will-be-presented-at-the-society-of-nuclear-medicine-and-molecular-imaging-snmmi-annual-meeting-alongside-pre-clinical-cd3-t-cell-imaging-data-300095089.html |
| |
|
Related News
|
» SPAR International Announces Strong Growth Plans for India
» Local ISP's Cutting Edge Service Delivers Live Streaming Capability for 'Biggest High-Tech Wedding in History'
|
